1.      Azari AA, Arabi A. Conjunctivitis: a systematic review. J Ophthalmic Vis Res. 2020;15(3):372. doi:10.18502/jovr.v15i3.7456.

2.      Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721–1729.

3.      Chen YS, Lin YH, Lee YH, et al. Efficacy of povidone-iodine-containing therapies for treatment of adenoviral conjunctivitis: a systematic review and network meta-analysis. Acta Ophthalmol. 2023;101(7):826–827.

4.      Chen YY, Liu SH, van Schayck OCP, et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2023;3:CD001211.

5.      Cheung AY, de Alba MA, Karp CL, et al. Conjunctivitis Preferred Practice Pattern® – 2023 Update. Ophthalmology. 2024;131(1).

6.      Epidemic Keratoconjunctivitis. EyeWiki (American Academy of Ophthalmology).

7.      Gin C. Conjunctivitis: a review. Aust J Gen Pract. 2024;53(11). (Güncel pratisyen odaklı derleme).

8.      Hashmi MF, Malik SS, Khan MA. Conjunctivitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2024.

9.      Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008;86(1):5–17.

10.  Høvding G. Acute bacterial conjunctivitis. Tidsskr Nor Laegeforen. 2004;124(11):1510–1512.

11.  Jhanji V, Chan TCY, Li EYM, et al. Adenoviral keratoconjunctivitis. Surv Ophthalmol. 2015;60(5):435–443.

12.  Khan A, Anders A, Cardonell M. Neonatal conjunctivitis. NeoReviews. 2022;23(9):e603–e612.

13.  Kovalyuk N, Mimouni K, Kaiserman I, et al. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study. Acta Ophthalmol. 2017;95(7).

14.  Kuo IC. Adenoviral keratoconjunctivitis: diagnosis, management, and prevention. Curr Ophthalmol Rep. 2019;7(2):118–127.

15.  Linton E, Thakore N, Feehan A, et al. Adult conjunctivitis secondary to dual infection with Chlamydia trachomatis and Neisseria gonorrhoeae: a case report and review. IDCases. 2019;18:e00617.

16.  Martín-Moro JG, Zarallo-Gallardo J, Guzmán-Almagro E, et al. A systematic review and meta-analysis on the efficacy of topical povidone iodine in adenoviral conjunctivitis. Contact Lens Anterior Eye. 2023;46(3):101873.

17.  Patel PB, Diaz MC, Bennett JE, et al. Clinical features of bacterial conjunctivitis in children. Acad Emerg Med. 2007;14(1):1–5. doi:10.1197/j.aem.2006.06.052.

18.  Pepose JS, Ahuja A, Liu W, et al. Direct and indirect costs of infectious conjunctivitis in a large US managed care population. Clin Ophthalmol. 2020;14:903–913.

19.   Pepose JS, Ahuja A, Liu W, et al. Randomized, controlled, phase 2 trial of povidone-iodine/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol. 2018;194:7–15.

20.  Pippin MM, Le JK. Bacterial Conjunctivitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2023.

21.  Rodrigues R, Pires C, Sousa C, et al. Addressing challenges in Chlamydia trachomatis detection. Medicina (Kaunas). 2024;60(8):1236. doi:10.3390/medicina60081236.

22.  Sheikh A, Hurwitz B, van Schayck CP, et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2012;(9):CD001211.

23.  Shunmugam M, Gunasekeran DV, Ooi KG-J, et al. An update on viral conjunctivitis treatment strategies: a narrative literature review. Microorganisms. 2025;13(8):1712.

24.  Varu DM, Rhee MK, Akpek EK, et al. Conjunctivitis Preferred Practice Pattern®. Ophthalmology. 2019;126(1):P94–P169.